Graphite Bio Alpha and Beta Analysis
GRPHDelisted Stock | USD 2.67 0.05 1.84% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Graphite Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Graphite Bio over a specified time horizon. Remember, high Graphite Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Graphite Bio's market risk premium analysis include:
Beta (0.21) | Alpha (0.08) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Graphite |
Graphite Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Graphite Bio market risk premium is the additional return an investor will receive from holding Graphite Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Graphite Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Graphite Bio's performance over market.α | -0.08 | β | -0.21 |
Graphite Bio Fundamentals Vs Peers
Comparing Graphite Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Graphite Bio's direct or indirect competition across all of the common fundamentals between Graphite Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Graphite Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Graphite Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Graphite Bio by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Graphite Bio to competition |
Fundamentals | Graphite Bio | Peer Average |
Return On Equity | -0.52 | -0.31 |
Return On Asset | -0.18 | -0.14 |
Current Valuation | 1.88 M | 16.62 B |
Shares Outstanding | 58.24 M | 571.82 M |
Shares Owned By Insiders | 9.17 % | 10.09 % |
Shares Owned By Institutions | 84.40 % | 39.21 % |
Number Of Shares Shorted | 704.04 K | 4.71 M |
Graphite Bio Opportunities
Graphite Bio Return and Market Media
The Stock received some media coverage during the period.About Graphite Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Graphite or other delisted stocks. Alpha measures the amount that position in Graphite Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Graphite Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of Graphite Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Graphite Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Graphite Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Graphite Bio. Please utilize our Beneish M Score to check the likelihood of Graphite Bio's management manipulating its earnings.
18th of March 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
18th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Graphite Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stocks Directory Find actively traded stocks across global markets |